See also this year's filing and all EDGAR filings for this company.
PDF Report 0000899866_2020_Alexion_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000899866, Alexion Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 5,076,400,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 8,381,700,000 |
| 2 | PropertyPlantAndEquipmentNet | 1,163,300,000 |
| 3 | remainder_Assets | 2,923,200,000 |
| 4 | LiabilitiesCurrent | 1,194,300,000 |
| 5 | LiabilitiesNoncurrent | 2,804,700,000 |
| 6 | remainder_Liabilities | 2,273,800,000 |
| 7 | CostOfGoodsAndServicesSold | 391,302,474 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,430,370,012 |
| 9 | ResearchAndDevelopmentExpense | 1,392,822,053 |
| 10 | remainder_Expenses | -744,103,881 |
| 11 | remainder_Revenues | 8,032,894,728 |
| 12 | remainder_NetIncome | 135,606,503 |
| 13 | remainder_ComprehensiveNetIncome | -13,234,485 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 17,544,600,000 |
| 1 | Liabilities | 6,272,800,000 |
| 2 | Expenses | 2,470,390,658 |
| 3 | Revenues | 8,032,894,728 |
| 4 | StockholdersEquity | 11,271,800,000 |
| 5 | NetIncome | 5,698,110,573 |
| 6 | ComprehensiveNetIncome | 5,691,493,330 |
| 7 | BaseVar | 17,234,763,187 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.54 |
| 9 | EconomicCapitalRatio | 3.38 |
Edgar->Model Mapping
Feature Distribution
Change over Time
